Nektar Therapeutics kondigt voorgenomen publieke aandelenuitgifte aan

Nektar Therapeutics has announced a proposed public offering of shares, according to a stock market report. Such offerings are typically used by companies to raise capital for operational or development purposes. No further details about the size or terms of the offering have been provided in the available information.